FAKTOR-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000SV9TZG7

Delayed Deutsche Boerse AG 10:07:08 23/05/2024 BST
3.07 EUR +2.33% Intraday chart for FAKTOR-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-20.00%
1 month-33.63%
Date Price Change
23/05/24 3.07 +2.33%
22/05/24 3 +16.73%
21/05/24 2.57 +8.44%
20/05/24 2.37 +2.16%
17/05/24 2.32 -5.69%

Delayed Quote Deutsche Boerse AG

Last update May 23, 2024 at 10:07 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Société Générale Société Générale
WKN SV9TZG
ISINDE000SV9TZG7
Date issued 19/07/2023
Strike 47.61
Maturity Unlimited
Parity 1 : 1
Emission price 10.31
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 69.6
Lowest since issue 2.24
Spread 0.08
Spread %2.52%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.75 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.82%
Consensus